Selected research
Market Analysis & Forecast
Global Substance P Market Analysis and Forecast 2026-2032
Market perspective
The global Substance P market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Substance P is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Substance P is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Substance P is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Substance P is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Substance P include Tocris Bioscience, R and D Systems, Peptide Institute, Genscript and BioCrick, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Substance P, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Substance P, also provides the sales of main regions and countries. Of the upcoming market potential for Substance P, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Substance P sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Substance P market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Substance P sales, projected growth trends, production technology, application and end-user industry.
Substance P Segment by Company
Tocris Bioscience
R and D Systems
Peptide Institute
Genscript
BioCrick
Substance P Segment by Type
Rat
Bovine
Human
Mouse
Substance P Segment by Application
Scientific Research
Medical
Others
Substance P Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Substance P market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Substance P and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Substance P.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Substance P in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Substance P manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Substance P sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rat
- Bovine
- Human
- Mouse
Applications
- Scientific Research
- Medical
- Others
Companies covered
- Tocris Bioscience
- R and D Systems
- Peptide Institute
- Genscript
- BioCrick
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Substance P Market by Type
- 1.2.1 Global Substance P Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Rat
- 1.2.3 Bovine
- 1.2.4 Human
- 1.2.5 Mouse
- 1.3 Substance P Market by Application
- 1.3.1 Global Substance P Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Scientific Research
- 1.3.3 Medical
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Substance P Market Dynamics
- 2.1 Substance P Industry Trends
- 2.2 Substance P Industry Drivers
- 2.3 Substance P Industry Opportunities and Challenges
- 2.4 Substance P Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Substance P Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Substance P Revenue by Region
- 3.2.1 Global Substance P Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Substance P Revenue by Region (2021-2026)
- 3.2.3 Global Substance P Revenue by Region (2027-2032)
- 3.2.4 Global Substance P Revenue Market Share by Region (2021-2032)
- 3.3 Global Substance P Sales Estimates and Forecasts 2021-2032
- 3.4 Global Substance P Sales by Region
- 3.4.1 Global Substance P Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Substance P Sales by Region (2021-2026)
- 3.4.3 Global Substance P Sales by Region (2027-2032)
- 3.4.4 Global Substance P Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Substance P Revenue by Manufacturers
- 4.1.1 Global Substance P Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Substance P Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Substance P Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Substance P Sales by Manufacturers
- 4.2.1 Global Substance P Sales by Manufacturers (2021-2026)
- 4.2.2 Global Substance P Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Substance P Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Substance P Sales Price by Manufacturers (2021-2026)
- 4.4 Global Substance P Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Substance P Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Substance P Manufacturers, Product Type & Application
- 4.7 Global Substance P Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Substance P Market CR5 and HHI
- 4.8.2 2025 Substance P Tier 1, Tier 2, and Tier 3
5 Substance P Market by Type
- 5.1 Global Substance P Revenue by Type
- 5.1.1 Global Substance P Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Substance P Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Substance P Revenue Market Share by Type (2021-2032)
- 5.2 Global Substance P Sales by Type
- 5.2.1 Global Substance P Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Substance P Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Substance P Sales Market Share by Type (2021-2032)
- 5.3 Global Substance P Price by Type
6 Substance P Market by Application
- 6.1 Global Substance P Revenue by Application
- 6.1.1 Global Substance P Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Substance P Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Substance P Revenue Market Share by Application (2021-2032)
- 6.2 Global Substance P Sales by Application
- 6.2.1 Global Substance P Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Substance P Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Substance P Sales Market Share by Application (2021-2032)
- 6.3 Global Substance P Price by Application
7 Company Profiles
- 7.1 Tocris Bioscience
- 7.1.1 Tocris Bioscience Company Information
- 7.1.2 Tocris Bioscience Business Overview
- 7.1.3 Tocris Bioscience Substance P Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Tocris Bioscience Substance P Product Portfolio
- 7.1.5 Tocris Bioscience Recent Developments
- 7.2 R and D Systems
- 7.2.1 R and D Systems Company Information
- 7.2.2 R and D Systems Business Overview
- 7.2.3 R and D Systems Substance P Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 R and D Systems Substance P Product Portfolio
- 7.2.5 R and D Systems Recent Developments
- 7.3 Peptide Institute
- 7.3.1 Peptide Institute Company Information
- 7.3.2 Peptide Institute Business Overview
- 7.3.3 Peptide Institute Substance P Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Peptide Institute Substance P Product Portfolio
- 7.3.5 Peptide Institute Recent Developments
- 7.4 Genscript
- 7.4.1 Genscript Company Information
- 7.4.2 Genscript Business Overview
- 7.4.3 Genscript Substance P Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Genscript Substance P Product Portfolio
- 7.4.5 Genscript Recent Developments
- 7.5 BioCrick
- 7.5.1 BioCrick Company Information
- 7.5.2 BioCrick Business Overview
- 7.5.3 BioCrick Substance P Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 BioCrick Substance P Product Portfolio
- 7.5.5 BioCrick Recent Developments
8 North America
- 8.1 North America Substance P Market Size by Type
- 8.1.1 North America Substance P Revenue by Type (2021-2032)
- 8.1.2 North America Substance P Sales by Type (2021-2032)
- 8.1.3 North America Substance P Price by Type (2021-2032)
- 8.2 North America Substance P Market Size by Application
- 8.2.1 North America Substance P Revenue by Application (2021-2032)
- 8.2.2 North America Substance P Sales by Application (2021-2032)
- 8.2.3 North America Substance P Price by Application (2021-2032)
- 8.3 North America Substance P Market Size by Country
- 8.3.1 North America Substance P Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Substance P Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Substance P Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Substance P Market Size by Type
- 9.1.1 Europe Substance P Revenue by Type (2021-2032)
- 9.1.2 Europe Substance P Sales by Type (2021-2032)
- 9.1.3 Europe Substance P Price by Type (2021-2032)
- 9.2 Europe Substance P Market Size by Application
- 9.2.1 Europe Substance P Revenue by Application (2021-2032)
- 9.2.2 Europe Substance P Sales by Application (2021-2032)
- 9.2.3 Europe Substance P Price by Application (2021-2032)
- 9.3 Europe Substance P Market Size by Country
- 9.3.1 Europe Substance P Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Substance P Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Substance P Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Substance P Market Size by Type
- 10.1.1 China Substance P Revenue by Type (2021-2032)
- 10.1.2 China Substance P Sales by Type (2021-2032)
- 10.1.3 China Substance P Price by Type (2021-2032)
- 10.2 China Substance P Market Size by Application
- 10.2.1 China Substance P Revenue by Application (2021-2032)
- 10.2.2 China Substance P Sales by Application (2021-2032)
- 10.2.3 China Substance P Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Substance P Market Size by Type
- 11.1.1 Asia Substance P Revenue by Type (2021-2032)
- 11.1.2 Asia Substance P Sales by Type (2021-2032)
- 11.1.3 Asia Substance P Price by Type (2021-2032)
- 11.2 Asia Substance P Market Size by Application
- 11.2.1 Asia Substance P Revenue by Application (2021-2032)
- 11.2.2 Asia Substance P Sales by Application (2021-2032)
- 11.2.3 Asia Substance P Price by Application (2021-2032)
- 11.3 Asia Substance P Market Size by Country
- 11.3.1 Asia Substance P Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Substance P Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Substance P Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Substance P Market Size by Type
- 12.1.1 SAMEA Substance P Revenue by Type (2021-2032)
- 12.1.2 SAMEA Substance P Sales by Type (2021-2032)
- 12.1.3 SAMEA Substance P Price by Type (2021-2032)
- 12.2 SAMEA Substance P Market Size by Application
- 12.2.1 SAMEA Substance P Revenue by Application (2021-2032)
- 12.2.2 SAMEA Substance P Sales by Application (2021-2032)
- 12.2.3 SAMEA Substance P Price by Application (2021-2032)
- 12.3 SAMEA Substance P Market Size by Country
- 12.3.1 SAMEA Substance P Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Substance P Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Substance P Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Substance P Value Chain Analysis
- 13.1.1 Substance P Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Substance P Production Mode & Process
- 13.2 Substance P Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Substance P Distributors
- 13.2.3 Substance P Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst